Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2017 Jul 8;19(8):1613–1627. doi: 10.1093/pm/pnx151

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2017 American Academy of Pain Medicine.

This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work properly cited. For commercial re-use, please contact journals.permissions@oup.com

PMC Copyright notice

Prevalence of oral abuse that involved product manipulation prior to oral ingestion among oral abusers of target products. *Crush-resistant tablet (CRT) products significantly greater than comparator products at P < 0.0001. ^†CRT products significantly greater than comparator products at P = 0.0027. Note: The denominator for each drug category is individuals who report any oral abuse of at least one of the products included in the category (see Table 1). The numerator is individuals who abused the product by an oral mode that involved product manipulation. CI = confidence interval; CRT = crush-resistant tablet; ER = extended-release; IR = immediate-release; MOA = mode of administration; SE = single entity.